|Day Low/High||13.80 / 13.94|
|52 Wk Low/High||13.84 / 19.96|
Japan is a leader in pharmaceuticals and has three companies working overtime to develop treatments for Covid-19.
The Medical Technology Stock Letter's top pick rose 357% in 2019.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
One of pharma's biggest CEO's talks M&A action on the exchange.